Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2022-06-02
Summary
Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent disorder which is directly linked to lifestyle patterns and is associated with poor quality of life, increased fatigue and psychological distress. The aim of the current study is to evaluate quality of life, fatigue and psychological functioning in NAFLD patients and assess the impact of systematic counseling on patients' psychosocial functioning.
Conditions
- Non-Alcoholic Fatty Liver Disease
Interventions
- OTHER
-
Motivational Interviewing
Regular sessions of Motivational Interviewing at 2 weeks and then at monthly intervals for a period of 6 months
Sponsors & Collaborators
-
University Hospital of Patras
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2020-12-31
- Completion
- 2022-12-01
Countries
- Greece
Study Locations
More Related Trials
-
Ambulatory Liver Fat Monitoring in Patients With Non-alcoholic Fatty Liver Disease
NCT05754385 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PK and Biomarkers After UDCA Administrations to Subjects Who Are Overweight and Have Liver Problems
NCT03000218 ·Status: UNKNOWN ·Phase: PHASE1
-
Probiotics in the Treatment of NAFLD
NCT02764047 ·Status: UNKNOWN ·Phase: NA
-
Lifestyle Modification in Psoriatic Patients With Fatty Liver
NCT05125757 ·Status: UNKNOWN ·Phase: NA
-
Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study
NCT05309642 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Natural Components Mixture in the Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02369536 ·Status: COMPLETED ·Phase: NA
-
Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
NCT07238985 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
2-Week Study In People With Nonalcoholic Fatty Liver Disease
NCT03513588 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease
NCT05200585 ·Status: COMPLETED ·Phase: NA
-
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT06127225 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
NCT02173080 ·Status: COMPLETED
-
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
NCT04550481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease
NCT05364684 ·Status: COMPLETED ·Phase: PHASE2
-
Probiotics in NASH Patients - PROBILIVER TRIAL
NCT03467282 ·Status: UNKNOWN ·Phase: NA
-
Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology
NCT05605821 ·Status: NOT_YET_RECRUITING
-
Treatment of Non Alcoholic Fatty Liver Disease With Lifestyle Modification and Acupuncture
NCT02006329 ·Status: UNKNOWN ·Phase: NA
-
6-week Safety and PD Study in Adults With NAFLD
NCT03256526 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease
NCT01139632 ·Status: UNKNOWN
-
Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH
NCT05357248 ·Status: COMPLETED ·Phase: NA
-
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids
NCT00760513 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients
NCT01811472 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment
NCT04308980 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
NCT02217345 ·Status: COMPLETED ·Phase: PHASE2